THE EFFECT OF HERBESSER ON NO-REFLOW AND IN THE ROLE OF IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PCI

被引：0
|
作者：
Zhang-Qiang, C. [1 ]
Lang, H. [1 ]
Min, Y. [2 ]
机构：
[1] Jiangxi Prov Peoples Hosp, Dept Cardiol, Nanchang 330006, Peoples R China
[2] Beijing Fu Wai Hosp, Beijing 100037, Peoples R China
来源：
HEART | 2015年 / 101卷
关键词：
D O I：
10.1136/heartjnl-2014-307109.77
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ASSA140801
引用
收藏
页码：A30 / A30
页数：1
相关论文
共 50 条
  • [21] Effect of empagliflozin on no-reflow in patients with st elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Nasef, M. A.
    Saber, M.
    Gomaa, Y.
    Kamal, D.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [22] Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI
    Dogan, Nazile Bilgin
    Ozpelit, Ebru
    Akdeniz, Selma
    Bilgin, Muzaffer
    Baris, Nezihi
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (03) : 576 - 581
  • [23] The Association Between Atherogenic Index of Plasma and No-Reflow Phenomenon in Acute Coronary Syndrome
    Celik, Ibrahim Etem
    Ozturk, Selcuk
    Yarlioglu, Mikail
    Barutcu, Ozan
    Akgun, Onur
    Duran, Mustafa
    Yorulmaz, Sukru
    Murat, Sani Namik
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2023, 27 (12): : 712 - 719
  • [24] Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome
    Song, Nian-Peng
    Zhen, Xiao-Wen
    Li, Liu-dong
    Zhong, Lin
    Wang, Hua
    An, Yi
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
  • [25] Autologous blood injection intracoronary artery for treating slow-flow and no-reflow in acute coronary syndrome related to primary pci
    Lam Truong Hoai
    Duy Nguyen Xuan
    Hung Nguyen Duc
    Long Nguyen Tuan
    CLINICAL CASE REPORTS, 2022, 10 (02):
  • [26] Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome
    Nian-Peng Song
    Xiao-Wen Zhen
    Liu-dong Li
    Lin Zhong
    Hua Wang
    Yi An
    BMC Cardiovascular Disorders, 20
  • [27] EFFECTS OF INTRACORONARY DILTIAZEM AND SODIUM NITROPRUSSIDE ON NO-REFLOW PHENOMENON AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Zhang-Qiang, C.
    Lang, H.
    Min, Y.
    Hong, W.
    Qiu-lin, Y.
    Lin-Feng, L.
    HEART, 2015, 101 : A40 - A40
  • [28] No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score
    Dawson, Luke P.
    Rashid, Muhammad
    Dinh, Diem T.
    Brennan, Angela
    Bloom, Jason E.
    Biswas, Sinjini
    Lefkovits, Jeffrey
    Shaw, James A.
    Chan, William
    Clark, David J.
    Oqueli, Ernesto
    Hiew, Chin
    Freeman, Melanie
    Taylor, Andrew J.
    Reid, Christopher M.
    Ajani, Andrew E.
    Kaye, David M.
    Mamas, Mamas A.
    Stub, Dion
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (04) : E013738
  • [29] Differential microRNAs expression profile in coronary thrombi from patients with no-reflow after primary PCI
    De Rosa, S.
    Iaconetti, C.
    Di Martino, M. T.
    Ambrosio, G.
    Sorrentino, S.
    Polimeni, A.
    Arabia, G.
    Filippis, C.
    Sabatino, J.
    Spaccarotella, C.
    Torella, D.
    Mongiardo, A.
    Tassone, P.
    Indolfi, C.
    EUROPEAN HEART JOURNAL, 2016, 37 : 847 - 848
  • [30] Treatment patterns in acute coronary syndrome patients in the United Kingdom undergoing PCI
    Bakhai, Ameet
    Iniguez, Andres
    Ferrieres, Jean
    Schmitt, Claude
    Sartral, Magali
    Belger, Mark
    Zeymer, Uwe
    EUROINTERVENTION, 2011, 6 (08) : 992 - 996
12345